The examination of the animal distribution according to EAE clinical scores, 30 days after MOG immunization, revealed that the beneficial effects of 11C7 come mainly from a reduction in the number of mice with paraparesis (Fig. 4D). The gene discussed is MOG; the disease is Paraparesis.